If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
established risk allele |
risk factor |
not provided |
total |
114
|
49
|
432
|
305
|
110
|
1
|
5
|
19
|
960
|
Gene and significance breakdown #
Total genes and gene combinations: 33
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
established risk allele |
risk factor |
not provided |
total |
PSEN1
|
75
|
33
|
157
|
70
|
36
|
0 |
0 |
13
|
357
|
APP
|
19
|
3
|
150
|
142
|
40
|
0 |
0 |
4
|
331
|
PSEN2
|
9
|
1
|
93
|
75
|
32
|
0 |
0 |
2
|
195
|
APP, LOC126653330
|
0 |
0 |
8
|
7
|
0 |
0 |
0 |
0 |
15
|
HFE
|
3
|
2
|
7
|
0 |
0 |
0 |
0 |
0 |
12
|
APOE
|
1
|
2
|
5
|
3
|
0 |
1
|
1
|
0 |
10
|
MPO
|
1
|
1
|
1
|
1
|
0 |
0 |
0 |
0 |
4
|
NOS3
|
0 |
0 |
2
|
1
|
1
|
0 |
0 |
0 |
4
|
ADAM10
|
0 |
0 |
0 |
1
|
0 |
0 |
2
|
0 |
3
|
ABCA7
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
0 |
2
|
APP, APP-DT
|
0 |
0 |
1
|
2
|
0 |
0 |
0 |
0 |
2
|
CSF1R
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
LOC129932678, PSEN2
|
0 |
0 |
0 |
1
|
1
|
0 |
0 |
0 |
2
|
VPS13C
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
ADAMTS1, ADAMTS5, APP, ATP5PF, BTG3, C21orf91, CHODL, CXADR, CYYR1, GABPA, HSPA13, JAM2, LIPI, MIR125B2, MIR155, MIR99A, MIRLET7C, MRPL39, NCAM2, NRIP1, POTED, RBM11, SAMSN1, TMPRSS15, USP25
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
ADAMTS1, ADAMTS5, APP, ATP5PF, CYYR1, GABPA, JAM2, MIR155, MRPL39
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
APP, GABPA
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
CLU
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
GRID2IP
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
GRN
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
LOC106694315, MPO
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
LOC106694316, MPO
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
LOC129388763, LOC129932680, PSEN2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
MAPT
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
MT-ND1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
PCDH11X
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
PLCD1
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
PLD3
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
SORCS1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
TM2D3
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
TNK1
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
UNC13C
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
VCP
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
established risk allele |
risk factor |
not provided |
total |
Invitae
|
61
|
16
|
242
|
253
|
66
|
0 |
0 |
0 |
638
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
168
|
45
|
55
|
0 |
0 |
0 |
268
|
OMIM
|
52
|
0 |
1
|
0 |
0 |
0 |
2
|
0 |
55
|
Fulgent Genetics, Fulgent Genetics
|
7
|
6
|
26
|
13
|
1
|
0 |
0 |
0 |
53
|
GeneReviews
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
19
|
20
|
Human Genetics Group at Institute of Prion Diseases London, University College London
|
1
|
10
|
0 |
0 |
0 |
0 |
0 |
0 |
11
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
|
0 |
0 |
8
|
0 |
0 |
0 |
2
|
0 |
10
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
5
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
9
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
9
|
0 |
0 |
0 |
9
|
Institute Of Human Genetics Munich, Klinikum Rechts Der Isar, Tu München
|
5
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
|
0 |
0 |
2
|
1
|
2
|
0 |
0 |
0 |
5
|
Mendelics
|
2
|
1
|
0 |
0 |
1
|
0 |
0 |
0 |
4
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
3
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
4
|
Neuberg Supratech Reference Laboratories Pvt Ltd, Neuberg Centre for Genomic Medicine
|
1
|
1
|
2
|
0 |
0 |
0 |
0 |
0 |
4
|
Kosik Lab, Neuroscience Research Institute, University of California Santa Barbara
|
2
|
1
|
0 |
0 |
1
|
0 |
0 |
0 |
4
|
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
|
0 |
1
|
2
|
0 |
0 |
0 |
0 |
0 |
3
|
Myllykangas group, University of Helsinki
|
0 |
0 |
1
|
2
|
0 |
0 |
0 |
0 |
3
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
1
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
3
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
3billion
|
1
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
3
|
Baylor Genetics
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Athena Diagnostics Inc
|
0 |
0 |
0 |
0 |
2
|
0 |
0 |
0 |
2
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
0 |
2
|
MGZ Medical Genetics Center
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Centogene AG - the Rare Disease Company
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Institute of Human Genetics, University of Leipzig Medical Center
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
2
|
Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Laboratory for Molecular Genetic Diagnostic of Neurological Diseases, University of Belgrade, School of Medicine
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Intergen, Intergen Genetics and Rare Diseases Diagnosis Center
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Alzheimer's disease and other cognitive disorders unit, Hospital Clínic de Barcelona_IDIBAPS
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
UCLA Clinical Genomics Center, UCLA
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Undiagnosed Diseases Network, NIH
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Genetics and Molecular Pathology, SA Pathology
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
SIB Swiss Institute of Bioinformatics
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
Laboratorio de Biología Molecular, FLENI
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Laboratory of Medical Genetics, University of Torino
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Johns Hopkins Genomics, Johns Hopkins University
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Codex Genetics Limited
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Department of Psychiatry and Medical Psychology, Medical University Pleven
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Fondazione Stella Maris
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Zotz-Klimas Genetics Lab, MVZ Zotz Klimas
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Neurogenomics Lab, Neuroscience Institute, University Of Cape Town
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.